Literature DB >> 27343071

Advanced interatrial block and ischemic stroke: The Atherosclerosis Risk in Communities Study.

Wesley T O'Neal1, Hooman Kamel2, Zhu-Ming Zhang2, Lin Y Chen2, Alvaro Alonso2, Elsayed Z Soliman2.   

Abstract

OBJECTIVE: Given that recent reports have suggested left atrial disease to be an independent risk factor for ischemic stroke, we sought to examine if advanced interatrial block (aIAB) is an independent stroke risk factor.
METHODS: We examined the association between aIAB and incident ischemic stroke in 14,716 participants (mean age 54 ± 5.8 years; 55% female; 26% black) from the Atherosclerosis Risk in Communities Study (ARIC). Cases of aIAB were identified from digital ECGs recorded during the baseline ARIC visit (1987-1989) and the first 3 follow-up study visits (1990-1992, 1993-1995, and 1996-1998). Adjudicated ischemic stroke events were ascertained through December 31, 2010.
RESULTS: There were 266 (1.8%) participants who had evidence of aIAB. Over a median follow-up of 22 years, 916 (6.2%) ischemic stroke events were detected. The incidence rate (per 1,000 person-years) of ischemic stroke among those with aIAB (incidence rate 8.05, 95% confidence interval [CI] 5.7, 11.4) was more than twice the rate in those without aIAB (incidence rate 3.14, 95% CI 2.94, 3.35). In a multivariable Cox regression analysis adjusted for stroke risk factors and potential confounders, aIAB was associated with an increased risk of ischemic stroke (hazard ratio 1.63, 95% CI 1.13, 2.34). The results were consistent across subgroups of participants stratified by age, sex, and race.
CONCLUSIONS: In the ARIC, aIAB was associated with incident ischemic stroke, which strengthens the hypothesis that left atrial disease should be considered an independent stroke risk factor.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Year:  2016        PMID: 27343071      PMCID: PMC4977113          DOI: 10.1212/WNL.0000000000002888

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Advanced Interatrial Block Predicts New Onset Atrial Fibrillation in Patients with Severe Heart Failure and Cardiac Resynchronization Therapy.

Authors:  Fariha Sadiq Ali; Andres Enriquez; Diego Conde; Damian Redfearn; Kevin Michael; Christopher Simpson; Hoshiar Abdollah; Antoni Bayés de Luna; Wilma Hopman; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-02       Impact factor: 1.468

2.  Interatrial block as a predictor of embolic stroke.

Authors:  Mojca Lorbar; Richard Levrault; Jayant G Phadke; David H Spodick
Journal:  Am J Cardiol       Date:  2005-03-01       Impact factor: 2.778

3.  The National Survey of Stroke. Study design and methodology.

Authors:  M Robins; F D Weinfeld
Journal:  Stroke       Date:  1981 Mar-Apr       Impact factor: 7.914

4.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

Authors:  W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

Review 5.  Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.

Authors:  Hooman Kamel; Peter M Okin; W T Longstreth; Mitchell S V Elkind; Elsayed Z Soliman
Journal:  Future Cardiol       Date:  2015-05

6.  Subclinical atrial fibrillation and the risk of stroke.

Authors:  Jeff S Healey; Stuart J Connolly; Michael R Gold; Carsten W Israel; Isabelle C Van Gelder; Alessandro Capucci; C P Lau; Eric Fain; Sean Yang; Christophe Bailleul; Carlos A Morillo; Mark Carlson; Ellison Themeles; Elizabeth S Kaufman; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

7.  New-onset atrial fibrillation after cavotricuspid isthmus ablation: identification of advanced interatrial block is key.

Authors:  Andres Enriquez; Axel Sarrias; Roger Villuendas; Fariha Sadiq Ali; Diego Conde; Wilma M Hopman; Damian P Redfearn; Kevin Michael; Christopher Simpson; Antoni Bayés De Luna; Antoni Bayés-Genís; Adrian Baranchuk
Journal:  Europace       Date:  2015-02-10       Impact factor: 5.214

Review 8.  Intra- and interatrial conduction delay: implications for cardiac pacing.

Authors:  Jean-Claude Daubert; Dominique Pavin; Gaël Jauvert; Philippe Mabo
Journal:  Pacing Clin Electrophysiol       Date:  2004-04       Impact factor: 1.976

9.  Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Elsayed Z Soliman; Ronald J Prineas; L Douglas Case; Zhu-ming Zhang; David C Goff
Journal:  Stroke       Date:  2009-02-12       Impact factor: 7.914

10.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

View more
  32 in total

1.  The prevalence and prognostic significance of interatrial block in the general population.

Authors:  Tiia Istolahti; Antti Eranti; Heini Huhtala; Leo-Pekka Lyytikäinen; Mika Kähönen; Terho Lehtimäki; Markku Eskola; Ismo Anttila; Antti Jula; Antoni Bayés de Luna; Kjell Nikus; Jussi Hernesniemi
Journal:  Ann Med       Date:  2020-03-14       Impact factor: 4.709

Review 2.  Bayes Syndrome and Imaging Techniques.

Authors:  Ivan Hernandez-Betancor; Maria Manuela Izquierdo-Gomez; Javier Garcia-Niebla; Ignacio Laynez-Cerdena; Martin Jesus Garcia-Gonzalez; A Barragan-Acea; Jose Luis Irribarren-Sarria; Juan Jose Jimenez-Rivera; Juan Lacalzada-Almeida
Journal:  Curr Cardiol Rev       Date:  2017

Review 3.  Intra- and interatrial conduction abnormalities: hemodynamic and arrhythmic significance.

Authors:  Nicolas Johner; Mehdi Namdar; Dipen C Shah
Journal:  J Interv Card Electrophysiol       Date:  2018-08-20       Impact factor: 1.900

4.  Abnormal P-Wave Axis and Ischemic Stroke: The ARIC Study (Atherosclerosis Risk In Communities).

Authors:  Ankit Maheshwari; Faye L Norby; Elsayed Z Soliman; Ryan J Koene; Mary R Rooney; Wesley T O'Neal; Alvaro Alonso; Lin Y Chen
Journal:  Stroke       Date:  2017-06-16       Impact factor: 7.914

Review 5.  Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.

Authors:  Shadi Yaghi; Hooman Kamel
Journal:  Stroke       Date:  2017-09-15       Impact factor: 7.914

6.  New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration).

Authors:  Bryce Alexander; Julia Milden; Bachar Hazim; Sohaib Haseeb; Antoni Bayes-Genis; Roberto Elosua; Manuel Martínez-Sellés; Cynthia Yeung; Wilma Hopman; Antoni Bayes de Luna; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-06-11       Impact factor: 1.468

7.  Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift?

Authors:  Antoni Bayés de Luna; Adrian Baranchuk; Manuel Martínez-Sellés; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-12-16       Impact factor: 1.468

8.  Rationale and design of the BAYES (Interatrial Block and Yearly Events) registry.

Authors:  Manuel Martínez-Sellés; Adrian Baranchuk; Roberto Elosua; Antonio Bayés de Luna
Journal:  Clin Cardiol       Date:  2016-11-24       Impact factor: 2.882

9.  Premature Atrial Contractions on the Screening Electrocardiogram and Risk of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke Study.

Authors:  Wesley T O'Neal; Hooman Kamel; Dawn Kleindorfer; Suzanne E Judd; George Howard; Virginia J Howard; Elsayed Z Soliman
Journal:  Neuroepidemiology       Date:  2016-08-17       Impact factor: 3.282

10.  Changes and significance of serum CXCL-16, GDF-15, PLA-2 levels in patients with cerebral infarction.

Authors:  Xiqi Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.